Pharmaceutical laws and regulations in Iran: An overview
The pharmaceutical legal framework is a very important infrastructure in achieving predefined goals in pharmaceutical sector: Accessibility, quality, and rational use of medicine. This study aims to review the current pharmaceutical sector-related legal provisions in Iran where the Food and Drug Org...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Wolters Kluwer Medknow Publications,
2016-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_bb1b7beaa30b4311a8c26f1cda01650f | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Pardis Zaboli |e author |
| 700 | 1 | 0 | |a Amir Hashemi-Meshkini |e author |
| 700 | 1 | 0 | |a Mehdi Varmaghani |e author |
| 700 | 1 | 0 | |a Hadi Gholami |e author |
| 700 | 1 | 0 | |a Iman Vazirian |e author |
| 700 | 1 | 0 | |a Hedieh-Sadat Zekri |e author |
| 700 | 1 | 0 | |a Shahriar Eslamitabar |e author |
| 700 | 1 | 0 | |a Abbas Kebriaeezadeh |e author |
| 245 | 0 | 0 | |a Pharmaceutical laws and regulations in Iran: An overview |
| 260 | |b Wolters Kluwer Medknow Publications, |c 2016-01-01T00:00:00Z. | ||
| 500 | |a 2319-9644 | ||
| 500 | |a 2279-042X | ||
| 500 | |a 10.4103/2279-042X.185709 | ||
| 520 | |a The pharmaceutical legal framework is a very important infrastructure in achieving predefined goals in pharmaceutical sector: Accessibility, quality, and rational use of medicine. This study aims to review the current pharmaceutical sector-related legal provisions in Iran where the Food and Drug Organization (FDO) is in charge of regulating all issues related to the pharmaceutical sector. The main laws and regulations enacted by parliament and cabinet and even internal regulations enacted by the Ministry of Health or Iran FDO are reviewed. Different laws and regulations are categorized according to the main goals of Iran national drug policy. | ||
| 546 | |a EN | ||
| 690 | |a Accessibility; availability; counterfeit medicines; pharmaceutical trade-related aspects; rational use of medicine | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Research in Pharmacy Practice, Vol 5, Iss 3, Pp 155-161 (2016) | |
| 787 | 0 | |n http://www.jrpp.net/article.asp?issn=2319-9644;year=2016;volume=5;issue=3;spage=155;epage=161;aulast=Zaboli | |
| 787 | 0 | |n https://doaj.org/toc/2319-9644 | |
| 787 | 0 | |n https://doaj.org/toc/2279-042X | |
| 856 | 4 | 1 | |u https://doaj.org/article/bb1b7beaa30b4311a8c26f1cda01650f |z Connect to this object online. |